These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3019982)

  • 21. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of polymyxin B nonapeptide to gram-negative bacteria.
    Vaara M; Viljanen P
    Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel derivatives of polymyxins.
    Vaara M
    J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.
    Vaara M; Porro M
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1801-5. PubMed ID: 8843284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
    Kubesch P; Wehsling M; Tümmler B
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):197-202. PubMed ID: 3118593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.
    Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C
    Front Immunol; 2022; 13():927017. PubMed ID: 36159837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
    Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
    J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
    Dixon RA; Chopra I
    Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental studies on administration method of chemotherapeutic agents. 16. Effect of polymyxin B against Pseudomonas aeruginosa (author's transl)].
    Obana Y; Ohtsuki M; Hirai Y; Nishino T
    Jpn J Antibiot; 1980 May; 33(5):636-40. PubMed ID: 6253700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.
    Rosenthal KS; Storm DR
    J Antibiot (Tokyo); 1977 Dec; 30(12):1087-92. PubMed ID: 202585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative effectiveness of gentamycin and other antibiotics in experiment].
    Navashin SM; Fomina IP; Kuznetsova SM
    Antibiotiki; 1969 Aug; 14(8):716-21. PubMed ID: 4314051
    [No Abstract]   [Full Text] [Related]  

  • 38. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli.
    Kubo A; Lunde CS; Kubo I
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1438-41. PubMed ID: 8726016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.